683-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
127
Total Value
1310485512
Accession Number
0001085146-25-003184
Form Type
13F-HR
Manager Name
683-Capital-Management
Data Enrichment
82% identified
104 identified23 unidentified

Holdings

127 positions • $1.3B total value
Manager:
Search and click to pin securities to the top
Page 3 of 7
601137102
Shares:355.0K
Value:$9.4M
% of Portfolio:0.7% ($9.4M/$1.3B)
488445206
Shares:1.2M
Value:$9.2M
% of Portfolio:0.7% ($9.2M/$1.3B)
CRESUD INC
Shares:830.0K
Value:$9.2M
% of Portfolio:0.7% ($9.2M/$1.3B)
Phathom Pharmaceuticals, Inc.
Shares:1.4M
Value:$9.1M
% of Portfolio:0.7% ($9.1M/$1.3B)
Howard Hughes Holdings Inc.
Shares:120.0K
Value:$8.9M
% of Portfolio:0.7% ($8.9M/$1.3B)
LENNAR CORP /NEW/
Shares:75.0K
Value:$8.6M
% of Portfolio:0.7% ($8.6M/$1.3B)
Amylyx Pharmaceuticals, Inc.
Shares:2.4M
Value:$8.5M
% of Portfolio:0.7% ($8.5M/$1.3B)
WESTERN ALLIANCE BANCORPORATION
Shares:110.0K
Value:$8.5M
% of Portfolio:0.6% ($8.5M/$1.3B)
IOVANCE BIOTHERAPEUTICS, INC.
Shares:2.4M
Value:$8.0M
% of Portfolio:0.6% ($8.0M/$1.3B)
Sage Therapeutics, Inc.
Shares:1.0M
Value:$8.0M
% of Portfolio:0.6% ($8.0M/$1.3B)
Aris Water Solutions, Inc.
Shares:1.6M
Value:$7.5M
% of Portfolio:0.6% ($7.5M/$1.3B)
Viking Therapeutics, Inc.
Shares:305.0K
Value:$7.4M
% of Portfolio:0.6% ($7.4M/$1.3B)
Apellis Pharmaceuticals, Inc.
Shares:333.0K
Value:$7.3M
% of Portfolio:0.6% ($7.3M/$1.3B)
594972AL5
Shares:
Value:$7.1M
% of Portfolio:0.5% ($7.1M/$1.3B)
38341PAA0
Shares:
Value:$7.0M
% of Portfolio:0.5% ($7.0M/$1.3B)
Gossamer Bio, Inc.
Shares:6.1M
Value:$6.7M
% of Portfolio:0.5% ($6.7M/$1.3B)
80004C200
Shares:140.0K
Value:$6.7M
% of Portfolio:0.5% ($6.7M/$1.3B)
Leidos Holdings, Inc.
Shares:48.8K
Value:$6.6M
% of Portfolio:0.5% ($6.6M/$1.3B)
450047303
Shares:501.0K
Value:$6.5M
% of Portfolio:0.5% ($6.5M/$1.3B)
Science Applications International Corp
Shares:50.0K
Value:$5.6M
% of Portfolio:0.4% ($5.6M/$1.3B)